First Covid-19 vaccine patent granted to CanSino in China: Report ࢀ" News

Dubai Page 0 Comments News Updates Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. Chinaࢀ™s vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its Covid-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the countryࢀ™s intellectual property regulator. It is the first Covid-19 vaccine patent granted by China, state-owned newspaper Peopleࢀ™s Daily reported on Sunday. The paper cited documents published by Chinaࢀ™s National Intellectual Property Administration saying that the patent was issued on August 11. Saudi Arabia said this month it plans to begin Phase…